Neutralizing antibody titres in SARS-CoV-2 infections.

Lau EHY, Tsang OTY, Hui DSC, Kwan MYW, Chan WH, Chiu SS, Ko RLW, Chan KH, Cheng SMS, Perera RAPM, Cowling BJ, Poon LLM, Peiris M. · 2021

Read Neutralizing antibody titres in SARS-CoV-2 infections. by Lau EHY, Tsang OTY, Hui DSC, Kwan MYW, Chan WH, Chiu SS, Ko RLW, Chan KH, Cheng SMS, Perera RAPM, Cowling BJ, Poon LLM, Peiris M. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7782739.txt.

Description

Lau and co-authors measure neutralizing antibody levels after SARS-CoV-2 infection. Such antibodies are a marker of protection. Data on how long they last were still scarce. The team tested 293 serum samples from 195 confirmed infections. Samples spanned 0 to 209 days after symptoms began.

Of samples taken at least 61 days after onset, 99.1% stayed positive. That held for both the 90% and 50% neutralization endpoints. Severe cases reached higher peak antibody levels than mild or silent cases. Age did not seem to weaken the response once severity was counted. The authors estimate slow decay over many months. They conclude that infection raises strong neutralizing antibody levels in most people.

Catalog record

CREATORLau EHY, Tsang OTY, Hui DSC, Kwan MYW, Chan WH, Chiu SS, Ko RLW, Chan KH, Cheng SMS, Perera RAPM, Cowling BJ, Poon LLM, Peiris M.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE32 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7782739

Browse the full library · About the Tower of Babel